BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Elion Therapeutics Announces Initiation of Turletricin (EL219) Phase 2 Study in Invasive Mould Infection

  April 16, 2026

   · 

  4 min read
• Press Releases

  Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026

  April 16, 2026

   · 

  2 min read
• Press Releases

  10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

  April 16, 2026

   · 

  1 min read
• Press Releases

  QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

  April 16, 2026

   · 

  7 min read
• Press Releases

  Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference

  April 16, 2026

   · 

  1 min read
• Press Releases

  IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

  April 16, 2026

   · 

  2 min read
• Press Releases

  Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026

  April 16, 2026

   · 

  1 min read
• Press Releases

  Glaukos Receives Permanent J-code for Epioxa™

  April 16, 2026

   · 

  6 min read
• Press Releases

  Savara Announces the U.S. Food & Drug Administration (FDA) Has Extended the Review Period for the Molgramostim Inhalation Solution (Molgramostim) Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

  April 16, 2026

   · 

  4 min read
• Press Releases

  CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results

  April 16, 2026

   · 

  6 min read